Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan vs valsartan for post-infarction ventricular remodeling in STEMI patients with diabetes
ChiCTR2300068678Phase 4Not yet recruiting
- Sponsor
- Liaoning Provincial People's Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in myocardial infarction (MI), type 2 diabetes mellitus (T2DM), cardiac remodeling and 1 more comparing Azilsartan group with Valsartan group (2 arms). Primary endpoints: Transthoracic echocardiography parameters and Cardiac magnetic resonance imaging parameters. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
azilsartanvalsartan
03
Conditions
myocardial infarction (MI)type 2 diabetes mellitus (T2DM)cardiac remodelingheart failure (HF)
Beyond the preview
Go deeper on ChiCTR2300068678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068678.